Coronavirus pandemic | Cipla to expand portfolio for COVID-19 drugs over next two months, says CFO

Coronavirus pandemic | Cipla to expand portfolio for COVID-19 drugs over next two months, says CFO Swiss company Regeneron has signed with Cipla for exclusive distribution of its imported antibody cocktail in India.

No comments:

Post a Comment